GLS2, FBXL5, NCOA4, and SAT1 proteins have also been repeatedly reported as therapeutic targets in cancer and have been used in multi-angle evaluation systems for preclinical investigations [48,51,135,136,137]. The gene discussed is NCOA4; the disease is cancer.